Search filters

List of works by Cosette M Wheeler

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

scientific article published on 16 April 2007

A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

article

A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears

scientific article

A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry

scientific article

A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study

scientific article published on May 2008

A controlled trial of a human papillomavirus type 16 vaccine

scientific article published in November 2002

A population-based evaluation of cervical screening in the United States: 2008-2011.

scientific article

A population‐based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination

scientific article published on June 20, 2012

A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study

scientific article

A study of the impact of adding HPV types to cervical cancer screening and triage tests

scientific article published on 01 January 2005

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

scientific article

Age-Specific Occurrence of HPV16- and HPV18-Related Cervical Cancer

scientific article published on April 30, 2013

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

scientific article published on January 2007

An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).

scientific article published on April 2008

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

scientific article published on October 2014

Beta-test Results for an HPV Information Web site: GoHealthyGirls.org - Increasing HPV Vaccine Uptake in the United States

scientific article

Cervical excisional treatment of young women: a population-based study

scientific article

Cervical histopathology variability among laboratories: a population-based statewide investigation

scientific article

Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update

scientific article published on 23 June 2006

Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study

scientific article

Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions

scientific article

Concurrence of multiple human papillomavirus infections in a large US population-based cohort

scientific article

Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548].

scientific article published on 30 April 2016

CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression

scientific article

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

scientific article published on 8 November 2011

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods

scientific article published on 25 November 2015

Detection of precancerous cervical lesions is differential by human papillomavirus type

scientific article

Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions

scientific article published on 01 October 2003

Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women

scientific article published in July 2004

EUROGIN 2007 roadmap—Conclusion

scientific article published on 01 March 2008

EUROGIN 2008 roadmap on cervical cancer prevention

scientific article

Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine

scientific article published in July 2004

Effect of the number of biopsies on the subsequent acquisition of new human papillomavirus infections

scientific article published in November 2009

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

scientific article published on 01 January 2006

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

scientific article published in November 2004

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

scientific article

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

scientific article published in May 2007

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials

scientific article

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial

scientific article published on 4 February 2015

Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA.

scientific article published in June 2010

Eurogin 2010 roadmap on cervical cancer prevention

scientific article published on 25 March 2011

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

scientific article published on 28 January 2017

Evaluation of a New DNA Test for Detection of Carcinogenic Human Papillomavirus

scientific article published on June 1, 2011

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

scientific article published in October 2009

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

scientific article published on January 2009

Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology

scientific article published on September 2008

Fewer than three doses of HPV vaccine - Authors' reply

scientific article published in September 2015

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

scientific article (publication date: 20 July 2010)

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

scientific article published on 16 October 2008

Health Service Accessibility and Risk in Cervical Cancer Prevention: Comparing Rural Versus Nonrural Residence in New Mexico

scientific article published on 24 August 2016

Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix

scientific article published on January 2003

Hierarchical Clustering of Human Papilloma Virus Genotype Patterns in the ASCUS-LSIL Triage Study

scientific article published on October 19, 2010

Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology

scientific article published in December 2005

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age

Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities

scientific article published on 16 September 2002

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region

scientific article

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

scientific article published on 24 March 2009

Human papillomavirus genotype specificity of hybrid capture 2

scientific article published on 25 June 2008

Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.

scientific article

Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer

scientific article published on 27 September 2006

Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3

scientific article

Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management

scientific article published on December 2014

Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease

scientific article

Human papillomavirus type 16 and 18 variants: race-related distribution and persistence

scientific article published on August 2006

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

scientific article published in July 2005

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

scientific article

Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

scientific article published on 27 January 2009

Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions.

scientific article published in July 2005

Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer

scientific article published in November 2004

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of

scientific article published on 01 December 2011

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

scientific article published on 15 May 2006

Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection

scientific article

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

scientific article

Impact of improved classification on the association of human papillomavirus with cervical precancer

scientific article

Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women

scientific article published on June 2010

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance

scientific article published on February 2011

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis

scientific article published on 29 September 2015

Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.

scientific article published on 13 March 2018

Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections

scientific article published on June 2009

Interlaboratory reliability of Hybrid Capture 2.

scientific article

Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs

scientific article

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study

scientific article

Need for expanded HPV genotyping for cervical screening

scientific article

New technologies in cervical cancer screening

scientific article published on August 2008

No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study

scientific article

Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines

scientific article

Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing

scientific article

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

scientific article published on 8 November 2011

Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.

scientific article published on 29 September 2016

Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico

scientific article published on September 2016

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

scientific article published on 27 June 2019

Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex t

scientific article

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology

scientific article published on 01 February 2010

Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline

scientific article

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

scientific article

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

scientific article published on 19 December 2015

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

scientific article

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

scientific article

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

scientific article

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

scientific article

Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.

scientific article

Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities

scientific article published on April 19, 2013

Risk of cervical intraepithelial neoplasia grade 2 or 3 after loop electrosurgical excision procedure associated with human papillomavirus type 16 variants

scientific article published on 19 March 2007

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial

scientific article published on 30 October 2014

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.

scientific article published on 8 March 2014

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

scientific article

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines

scientific article published on 3 November 2016

Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology

scientific article published in May 2005

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

scientific article (publication date: 15 April 2006)

TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer

scientific article published on 08 February 2005

The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy

scientific article published on December 1, 2011

The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status

scientific article

The impact of human papillomavirus vaccination on cervical cancer prevention efforts

scientific article published on May 2009

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

scientific article published on April 2009

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

scientific article published on April 2009

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States

scientific article

The safety of Cervarix? - Authors' reply

scientific article

Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test

scientific article published on January 2014

Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium

scientific article published on 30 March 2018

Usability Testing of an HPV Information Website for Parents and Adolescents

scientific article

Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.

scientific article

Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.

scientific article published in January 2007